| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50222-346-02 | 50222-346 | HUMAN PRESCRIPTION DRUG | Adbry | tralokinumab-ldrm | INJECTION, SOLUTION | SUBCUTANEOUS | 20220102 | N/A | BLA | BLA761180 | LEO Pharma Inc. | TRALOKINUMAB | 150 mg/mL | 2 SYRINGE, GLASS in 1 CARTON (50222-346-02) / 1 mL in 1 SYRINGE, GLASS (50222-346-01) |
| 50222-346-04 | 50222-346 | HUMAN PRESCRIPTION DRUG | Adbry | tralokinumab-ldrm | INJECTION, SOLUTION | SUBCUTANEOUS | 20220102 | N/A | BLA | BLA761180 | LEO Pharma Inc. | TRALOKINUMAB | 150 mg/mL | 2 CARTON in 1 CARTON (50222-346-04) / 2 SYRINGE, GLASS in 1 CARTON (50222-346-22) / 1 mL in 1 SYRINGE, GLASS (50222-346-01) |
| 50222-346-92 | 50222-346 | HUMAN PRESCRIPTION DRUG | Adbry | tralokinumab-ldrm | INJECTION, SOLUTION | SUBCUTANEOUS | 20220102 | N/A | BLA | BLA761180 | LEO Pharma Inc. | TRALOKINUMAB | 150 mg/mL | 2 SYRINGE, GLASS in 1 CARTON (50222-346-92) / 1 mL in 1 SYRINGE, GLASS (50222-346-91) |